![Paula Cobb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paula Cobb
Directeur des opérations chez
Manifold Biotechnologies, Inc.
Profil
Paula K.
Cobb is currently Director at NightstaRx Ltd. and Chief Operating Officer at Manifold Biotechnologies, Inc. Former positions include Independent Non-Executive Director at Nightstar Therapeutics Ltd. from 2018 to 2019, Independent Director at Prothena Corp.
Plc from 2019 to 2025, Senior Vice President-Rare Disease Group at Biogen, Inc. from 2015 to 2016, Chief Operating Officer at Decibel Therapeutics, Inc. in 2019, and Chief Business Officer at Affinia Therapeutics, Inc. from 2020 to 2023.
Education includes undergraduate studies at Amherst College and an MBA from Harvard Business School.
Postes actifs de Paula Cobb
| Sociétés | Poste | Début |
|---|---|---|
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Directeur/Membre du Conseil | - |
Manifold Biotechnologies, Inc.
 Manifold Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur des opérations | 01/12/2025 |
Anciens postes connus de Paula Cobb
| Sociétés | Poste | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Directeur/Membre du Conseil | 31/12/2025 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Corporate Officer/Principal | 01/01/2023 |
| DECIBEL THERAPEUTICS, INC. | Directeur des opérations | 01/12/2019 |
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Membre du Conseil | 07/06/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2016 |
Formation de Paula Cobb
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Manifold Biotechnologies, Inc.
Manifold Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Choisissez Zonebourse 
